Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000202431

Medchemexpress LLC Mc-gly-gly-phe-gly-gaba-exatecan | 1599439-52-7 | 99.7% | 1032.08 | C53H58FN9O12 | 5 MG
SDP

Catalog No. 5000202431
Encompass_Preferred

MC-Gly-Gly-Phe-Gly-GABA-Exatecan is a drug-linker conjugate designed for antibody-drug conjugate (ADC) research. It couples an Exatecan-derived cytotoxic payload to a Gly-Gly-Phe-Gly-GABA peptide linker and has demonstrated cytotoxic and antitumor activity in vitro and in vivo.

  • Has purity 99.72%.
  • Contains CAS number 1599439-52-7.
  • Molecular weight 1032.08.
  • Formula C53H58FN9O12.
  • Intended for antibody-drug conjugate development.
  • Available in small powder quantities (5 mg, 10 mg, 50 mg, 100 mg).
  • Documentation available: data sheet, certificate of analysis, and safety data sheet.

Catalog No. 50-002-02431 Supplier Medchemexpress LLC Supplier No. HY1606495MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

MC-Gly-Gly-Phe-Gly-GABA-Exatecan is a drug-linker conjugate designed for antibody-drug conjugate (ADC) research. It couples an Exatecan-derived cytotoxic payload to a Gly-Gly-Phe-Gly-GABA peptide linker and has demonstrated cytotoxic and antitumor activity in vitro and in vivo.

  • Has purity 99.72%.
  • Contains CAS number 1599439-52-7.
  • Molecular weight 1032.08.
  • Formula C53H58FN9O12.
  • Intended for antibody-drug conjugate development.
  • Available in small powder quantities (5 mg, 10 mg, 50 mg, 100 mg).
  • Documentation available: data sheet, certificate of analysis, and safety data sheet.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.